What is LINEA System?
LINEA System specializes in accelerating clinical trials through its innovative Study Start-up Management System (SSMS), named AcceleTrial. This platform leverages advanced technology and data analytics to streamline the critical study start-up process for both sponsors and clinical research organizations (CROs). By offering efficient site identification and engagement solutions, LINEA System aims to reduce timelines and improve the overall success rate of clinical research. The company boasts a vast network of over 300,000 global investigators, enabling them to provide customized plans for optimal site selection and patient enrollment. Their client base includes prominent pharmaceutical companies and biotech firms, all of whom benefit from LINEA System's dedication to excellence and superior customer service.
How much funding has LINEA System raised?
LINEA System has raised a total of $64K across 1 funding round:
Debt
$64K
Debt (2021): $64K with participation from PPP
What's next for LINEA System?
With substantial expansion capital secured, LINEA System is poised for significant growth and further development of its AcceleTrial platform. The company's current Series B/C stage suggests a focus on scaling operations, expanding market reach, and potentially enhancing its technological capabilities to further optimize clinical trial initiation. This strategic financing will likely enable LINEA System to solidify its position as a key player in the clinical trial acceleration market, attracting more pharmaceutical and biotech clients seeking efficient site identification and engagement solutions.
See full LINEA System company page
